KELSEY HARPER: Open Payments
NPI 1821798166 · HIGHLANDS RANCH, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,158 in 43 payments from 15 companies in 2025. Trend: 2023 $116 · 2024 $782 · 2025 $1,158
Food & beverage: $1,158
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 8 | $256 |
| AstraZeneca Pharmaceuticals LP | 6 | $179 |
| Otsuka America Pharmaceutical, Inc. | 4 | $112 |
| Novo Nordisk Inc | 4 | $111 |
| Travere Therapeutics, Inc. | 4 | $90 |
| Novartis Pharmaceuticals Corporation | 4 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| Amgen Inc. | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| SOBI, INC | 1 | $41 |
Products named: TARPEYO, LOKELMA, JARDIANCE, Ozempic, JYNARQUE, Fabhalta, KRYSTEXXA, Kerendia.
Industry payments across CO — which companies pay providers there.
